Stop parsing PDFs. Get the API. Request Access

AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Novonesis AS

Director's Dealing • Nov 4, 2025

3377_rns_2025-11-04_4441c36d-9887-4ea7-a638-2ec864df94a4.html

Director's Dealing

Open in Viewer

Opens in native device viewer

Trading by management and close relations of management

Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B. The released shares relate to the 2022 legacy Chr. Hansen matching shares program and the legacy Chr. Hansen 2023 restricted stock units (RSU) program. 

Attachment

More from Novonesis AS

Director's Dealing 2025
Nov 21
Director's Dealing 2025
Nov 21
Director's Dealing 2025
Nov 7
Director's Dealing 2025
Nov 7
Major Shareholding Notification 2025
Nov 7
Major Shareholding Notification 2025
Nov 7
Major Shareholding Notification 2025
Nov 7
Director's Dealing 2025
Nov 4
Major Shareholding Notification 2025
Sep 10
Major Shareholding Notification 2025
Sep 10
View all filings →

Talk to a Data Expert

Have a question? We'll get back to you promptly.